Molecular design and application of splice-switching antibody-oligonucleotide conjugate for hypertrophic cardiomyopathy-related MYBPC3 splice modulation.

Informazioni relative al progetto

HCMSpliceAOC

ID dell’accordo di sovvenzione: 101130771

DOI

10.3030/101130771

Progetto chiuso

Data della firma CE 15 Maggio 2023

Data di avvio 1 Giugno 2023

Data di completamento 31 Maggio 2025

Finanziato da

• Widening participation and spreading excellence

Costo totale

Nessun dato

Contributo UE

€ 156 778,56

Coordinato da

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE
Portugal

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Data Management Plan (1)

Data management plan

The DMP will describe the data that will be acquired or produced during the project; how these data will be managed, described, and stored. Additionally, it will define the standards to be used for both handling and protecting the data ensuring compliance with the FAIR principles. The DMP will define all the aspects of data management during and after the completion of the project. The first version of the DMP will be concluded in month 6 and it will be regularly updated throughout the project.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact of the project, including the dissemination and exploitation measures that are planned, and the target group(s) addressed. Regarding communication measures and public engagement strategy, the aim is to inform and reach out to society and show the activities performed, and the use and the benefits the project will have for citizens.